Canadian Oil Sands Upgraded by TD Securities to “Buy” (COS)

Share on StockTwits

Canadian Oil Sands (TSE:COS) was upgraded by equities researchers at TD Securities from a “hold” rating to a “buy” rating in a research report issued on Friday. The firm currently has a C$27.00 price target on the stock, up from their previous price target of C$24.00. TD Securities’ price objective would suggest a potential upside of 11.66% from the stock’s previous close.

A number of other firms have also recently commented on COS. Analysts at FirstEnergy Capital downgraded shares of Canadian Oil Sands to an “underperform” rating in a research note on Tuesday, May 6th. They now have a C$21.00 price target on the stock, down previously from C$22.00. Separately, analysts at Scotiabank reiterated a “sector underperform” rating on shares of Canadian Oil Sands in a research note on Thursday, May 1st. Finally, analysts at RBC Capital cut their price target on shares of Canadian Oil Sands from C$22.00 to C$21.00 in a research note on Thursday, May 1st. They now have an “underperform” rating on the stock. Six equities research analysts have rated the stock with a sell rating, four have given a hold rating and two have given a buy rating to the company’s stock. Canadian Oil Sands has a consensus rating of “Hold” and an average price target of C$23.22.

Canadian Oil Sands (TSE:COS) traded down 0.37% during mid-day trading on Friday, hitting $24.18. The stock had a trading volume of 828,709 shares. Canadian Oil Sands has a 1-year low of $19.28 and a 1-year high of $24.68. The stock’s 50-day moving average is $23.42 and its 200-day moving average is $21.90. The company has a market cap of $11.718 billion and a price-to-earnings ratio of 14.28.

Canadian Oil Sands Limited is a pure investment opportunity in light, sweet crude oil. Through its 36.

Receive News & Ratings for Canadian Oil Sands Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canadian Oil Sands Ltd and related companies with Analyst Ratings Network's FREE daily email newsletter.

Latest News

Seadrill Stock Rating Upgraded by RS Platou
Seadrill Stock Rating Upgraded by RS Platou
Steven Madden Rating Reiterated by Wunderlich
Steven Madden Rating Reiterated by Wunderlich
Vitae Pharmaceuticals Research Coverage Started at Stifel Nicolaus
Vitae Pharmaceuticals Research Coverage Started at Stifel Nicolaus
Vitae Pharmaceuticals Earns Outperform Rating from Analysts at BMO Capital Markets
Vitae Pharmaceuticals Earns Outperform Rating from Analysts at BMO Capital Markets
Yahoo! Stock Rating Reaffirmed by Pivotal Research
Yahoo! Stock Rating Reaffirmed by Pivotal Research
Analysts’ Ratings Reiterations for October, 21st
Analysts’ Ratings Reiterations for October, 21st


Leave a Reply

 
Advertisement
Advertisement
© 2006-2014 Mideast Time.